Shenzhen Salubris Pharmaceuticals Co., Ltd.

SZSE:002294.SZ

29.64 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Assets:
Current Assets:
Cash & Cash Equivalents 1,321.9752,670.4673,235.871865.1351,111.942645.111828.9221,713.7741,005.43851.422694.237958.77889.4761,005.6421,163.56452.27433.9296.651
Short Term Investments 881.566328.36260214.588208-65.949-56.888-47.95720-20.6932000000000
Cash and Short Term Investments 2,203.5412,998.8293,295.8711,079.7231,319.942645.111828.9221,713.7741,005.43851.422694.237958.77889.4761,005.6421,163.56452.27433.9296.651
Net Receivables 578.647626.982654.491597.41,221.2321,581.2531,496.481,513.1151,457.8741,316.731,206.675982.515718.277527.483287.41161.00598.89567.567
Inventory 490.857543.534420.455391.557503.155570.89477.846323.442340.543151.882160.475225.823168.285225.134150.47199.36674.27645.292
Other Current Assets 40.176542.07133.01663.24945.334641.665913.189100.36845.087210200.551-6.7483.67-6.91-5.971-12.715-7.297-5.43
Total Current Assets 3,313.2224,711.4164,403.8332,131.9283,089.6633,438.9193,716.4373,650.6992,848.9342,530.0352,261.9382,160.361,779.7081,751.3491,595.474299.929199.804114.08
Non-Current Assets:
Property, Plant & Equipment, Net 1,457.4281,505.9031,637.7321,507.4921,410.9531,266.1491,180.8851,081.7121,036.923871.993807.178612.235485.294366.382159.918105.02255.22143.325
Goodwill 10.91260.52787.13887.138369.858380.84687.13887.13887.138000000000
Intangible Assets 2,615.7792,184.5362,011.0171,981.6851,734.751,832.571,355.451,255.0171,200.7011,047.454519.322169.258155.80149.69811.46100.4240.849
Goodwill and Intangible Assets 2,626.6922,245.0632,098.1552,068.8232,104.6082,213.4161,442.5881,342.1551,287.8391,047.454519.322169.258155.80149.69811.46100.4240.849
Long Term Investments 1,733.335395.784641.822621.084660.401783.989381.64492.21641.33268.0891.2871.49801.7280000
Tax Assets 87.40188.27382.01398.26462.97657.05756.70650.57959.45772.38339.43521.32110.327.4485.1013.6520.4920.411
Other Non-Current Assets 178.595808.682380.33490.909404.695145.27486.122316.779112.39726.08814.09216.04814.016-1.7280000
Total Non-Current Assets 6,083.4515,043.7064,840.0524,786.574,643.6334,465.8853,147.9442,883.442,537.9482,086.0071,381.315820.359665.433423.527176.479108.67356.13744.585
Total Assets 9,396.6739,755.1229,243.8856,918.4987,733.2967,904.8046,864.3826,534.1395,386.8834,616.0423,643.2532,980.7192,445.1412,174.8771,771.954408.603255.941158.664
Liabilities & Equity:
Current Liabilities:
Account Payables 156.007219.647187.672223.387144.059119.24791.42876.787169.814104.969167.085121.522149.238207.99582.48460.62451.3319.887
Short Term Debt 50.927188.65169.985310.346184.408151515000000044.228.5513.68
Tax Payables 10.49268.87862.9835.26137.778214.614193.346182.063136.119151.419113.2884.96743.91312.19914.6058.8523.3834.158
Deferred Revenue 29.54942.665749.833561.171433.74214.614448.979866.664000000032.5120.8317.265
Other Current Liabilities 578.6011,152.6735.3512.08515.292326.22717.70310.099429.179688.069308.721211.328134.66884.86263.1028.374.2741.356
Total Current Liabilities 815.0841,603.6361,012.8411,096.99777.5675.089573.109968.549598.993793.038475.806332.851283.906292.857145.586145.704104.98452.188
Non-Current Liabilities:
Long Term Debt 12.53919.5839.11390158.928242.04304560000000050
Deferred Revenue Non-Current 84.11498.53593.71489.61384.11767.28580.59854.03932.25934.91600000000
Deferred Tax Liabilities Non-Current 13.03627.181-019.82221.66923.5166.789-38.517-60000000000
Other Non-Current Liabilities 332.3629.64182.57330.41224.7125.6715.3674560032.55741.17326.61116.6423000
Total Non-Current Liabilities 442.048174.94185.4229.847289.423358.511132.754105.52292.25934.91632.55741.17326.61116.6423050
Total Liabilities 1,257.1321,778.5761,198.2411,326.8371,066.9241,033.6705.8631,074.072691.251827.954508.363374.024310.517309.5148.586145.704109.98452.188
Equity:
Preferred Stock 00000000000.0210000000
Common Stock 1,114.8171,114.8171,114.8171,046.0161,046.0161,046.0161,046.0161,046.0161,046.016653.76653.76435.84363.2227113.5858572
Retained Earnings 5,037.4275,002.8934,803.5134,305.7874,822.0564,946.3864,324.9763,605.32,944.4892,224.5621,643.941,197.669788.353559.246352.627158.72653.47930.772
Accumulated Other Comprehensive Income/Loss 634.733591.06512.951484.272540.159524.167520.854527.072417.0710.14-0.0210000000
Other Total Stockholders Equity 1,232.0171,231.9651,602.453-327.74681.225144.358161.093181.938181.938901.074831.634970.475980.7441,077.0041,155.30819.1727.4783.704
Total Shareholders Equity 8,018.9947,940.7348,033.7345,508.336,489.4566,660.9286,052.9385,360.3264,589.5153,779.5363,129.3342,603.9842,132.2981,863.251,621.435262.899145.957106.476
Total Equity 8,055.4267,976.5468,045.6445,591.6626,666.3736,871.2056,158.5185,460.0674,695.6313,788.0883,134.8892,606.6952,134.6241,865.3771,623.367262.899145.957106.476
Total Liabilities & Shareholders Equity 9,396.6739,755.1229,243.8856,918.4987,733.2967,904.8046,864.3826,534.1395,386.8834,616.0423,643.2532,980.7192,445.1412,174.8771,771.954408.603255.941158.664